LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 3 of 15: Cell count and relative growth within biological replicate 3. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 3 of 15: Cell count and relative growth within biological replicate 3. - Dataset (ID:20239)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells

<
<<
Previous
Page 1 of 497
Next
>>
>
1 to 25 of 12420 records
per page:

Cell	Small Molecule	Small Mol Concentration	Small Mol Conc Unit	LJP Library Plate	Replicate	Assay Well	Timepoint	Timepoint Unit	Total Cell Count Before Treatment	Total Cell Count After Treatment	Total Control Cell Count	Relative Cell Count	Relative Growth Rate After Treatment
BT-20	Alpelisib	0.04	uM	LJP5	3	N06	72	hr	1097	3559	3769	0.9442	0.9212
BT-20	XMD11-85h	0.04	uM	LJP6	3	P24	72	hr	1097	2869	3769	0.7611	0.6630
BT-20	GDC-0980	0.04	uM	LJP5	3	K24	72	hr	1097	1550	3769	0.4112	0.1694
BT-20	KIN001-043	0.04	uM	LJP6	3	C12	72	hr	1097	3380	3769	0.8967	0.8542
BT-20	A443654	0.04	uM	LJP6	3	I24	72	hr	1097	2379	3769	0.6311	0.4796
BT-20	OSI-027	0.04	uM	LJP6	3	E12	72	hr	1097	3117	3769	0.8269	0.7558
BT-20	SNS-032	0.04	uM	LJP6	3	H18	72	hr	1097	3194	3769	0.8473	0.7846
BT-20	Sigma A6730	0.04	uM	LJP5	3	B24	72	hr	1097	3395	3769	0.9006	0.8598
BT-20	NVP-AEW541	0.04	uM	LJP5	3	E18	72	hr	1097	4136	3769	1.0972	1.1371
BT-20	AT-7519	0.04	uM	LJP6	3	K06	72	hr	1097	3011	3769	0.7988	0.7162
BT-20	BI-2536	0.04	uM	LJP6	3	D18	72	hr	1097	924	3769	0.2451	-0.0648
BT-20	Luminespib	0.04	uM	LJP5	3	H18	72	hr	1097	1087	3769	0.2884	-0.0038
BT-20	Afatinib	0.04	uM	LJP6	3	G24	72	hr	1097	2938	3769	0.7794	0.6888
BT-20	AZD 5438	0.04	uM	LJP6	3	J06	72	hr	1097	3107	3769	0.8242	0.7521
BT-20	AZD8330	0.04	uM	LJP5	3	G24	72	hr	1097	2766	3769	0.7338	0.6245
BT-20	BMS345541	0.04	uM	LJP6	3	D06	72	hr	1097	3562	3769	0.9449	0.9223
BT-20	AZD-6482	0.04	uM	LJP5	3	I06	72	hr	1097	3868	3769	1.0261	1.0368
BT-20	Alvocidib	0.04	uM	LJP6	3	A18	72	hr	1097	981	3769	0.2602	-0.0435
BT-20	Barasertib	0.04	uM	LJP5	3	D12	72	hr	1097	3176	3769	0.8425	0.7779
BT-20	AZD7762	0.04	uM	LJP6	3	L06	72	hr	1097	3937	3769	1.0444	1.0627
BT-20	SB590885	0.04	uM	LJP5	3	L18	72	hr	1097	3684	3769	0.9773	0.9680
BT-20	PIK-93	0.04	uM	LJP5	3	K18	72	hr	1097	3796	3769	1.0070	1.0099
BT-20	AZD8055	0.04	uM	LJP6	3	A12	72	hr	1097	1363	3769	0.3616	0.0994
BT-20	WH-4-025	0.04	uM	LJP5	3	O12	72	hr	1097	3876	3769	1.0282	1.0398
BT-20	HG-6-64-01	0.04	uM	LJP6	3	M06	72	hr	1097	3516	3769	0.9327	0.9051

<
<<
Previous
Page 1 of 497
Next
>>
>
1 to 25 of 12420 records
per page:

HMS LINCS Project

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 3 of 15: Cell count and relative growth within biological replicate 3. - Dataset (ID:20239)